Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the
Glycomics / Glycobiology Market
Request Now !
Glycomics or Glycobiology is the study of structure, biology, and function of saccharides which are widely distributed in nature and regarded as glycans as well. Glycans are found in all living organisms. Glycobiology is a rapidly progressing biological area of interest for various fields like biotechnology, biomedicine, and basic research. Most proteins are revised after the translation process in eukaryotic cells. The attachment of glycans is one of the most usual modifications for cell viability. There are two forms of glycosylation 1) N-linked glycosylation: when glycan is attached to asparagines 2) O-linked glycosylation: when the glycan is attached to a serine or threonine.
Glycobiology has a vast range of applicability like diagnostics, oncology, drug discovery & development, immunology, and various other applications. Glycomics is a widely emerging scientific field highlighting on defining functional aspects of glycans in biosystems.
Market scope and structure analysis:
Market size available for years
Base year considered
Application, Product, End-User, and Region
North America (U.S. and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa
Major players analyzed include Agilent Technologies, Waters Corporation, Lectenz Bio, Takara Bio, Thermo Fisher Scientific, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation and S-Bio.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on glycomics / glycobiology market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Rising investments in research and development of pharmaceutical and biotechnology companies and growth in the proteomics market are the major factors boosting glycomics / glycobiology market. Developing countries are providing profitable chances for other companies operating in this field. We are also witnessing technological advancements due to various investments in research by various governments and development in drugs by biotechnology and pharmaceutical companies are helping the growth. Additionally, we are also seeing glycomics and proteomics research studies interest increasing which is expected to propel market expansion shortly.
Different organizations have started academic researches to develop new glycomics and glycobiology tools. Procedures like protein characterizations are advancing due to innovations, such as High-Performance Liquid Chromatography (HPLC), and Mass Spectrometry (MS) in chemical and biochemical research. These techniques are providing rapid and highly sensitive results.
An increase in the demand for medicines for the treatment of several severe chronic diseases is also expected to flourish glycomics / glycobiology market growth.
On the other side, the high cost of tools is expected to hamper the market growth to a certain extent.
New product launches to flourish the market:
On June 4, 2018, Shimadzu Corp. and PREMIER Biosoft, introduced its LCMS-9030 Quadruple Time of Flight (Q-TOF) mass spectrometry system.
On November 15, 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System which is an integrated platform which is a user-friendly glycoanalysis.
On June 17, 2019, New England Biolabs and Waters Corporation announced a collaboration to accelerate glycomics research by providing goods and services critical to glycan analysis.
Surge in usage in Pharma and biotechnology companies:
They have been a lot of collaborations between major organizations and research institutes which are supporting the segment expansion. The pharma and biotechnology companies segment are growing due to increase in R&D investments.
There is a wide range of applications in drug discovery and development, cell biology, biomedical research, immunology, and biochemistry which are increasing the demand for glycomics / glycobiology market.
Key segments covered:
- Disease Diagnostics
- Drug Discovery & Development
- Reagents & Chemicals
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- Academic Research Institutes
- North America
- Latin America
- The Middle East and Africa
Key benefits of the report:
- This study presents the analytical depiction of the global Glycomics / Glycobiology industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Glycomics / Glycobiology market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the global market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Glycomics / Glycobiology market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Glycomics / Glycobiology Market research report:
- What are the leading market players active in the Glycomics / Glycobiology market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
CHAPTER 4 GLYCOMICS MARKET, BY PRODUCT
4.1.1. Market size and forecast
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
220.127.116.11. Market size and forecast
18.104.22.168. Market size and forecast
22.214.171.124. Market size and forecast
126.96.36.199. Market size and forecast
188.8.131.52. Market size and forecast
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Antibody Arrays
184.108.40.206. Market size and forecast
220.127.116.11. Market size and forecast
4.3.6. Lectin Arrays
18.104.22.168. Market size and forecast
22.214.171.124. Market size and forecast
4.3.8. Mass Spectrometers
126.96.36.199. Market size and forecast
4.3.9. Other Glycomics Instruments
188.8.131.52. Market size and forecast
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Glycan Labeling Kits
184.108.40.206. Market size and forecast
4.4.5. Glycan Purification Kits
220.127.116.11. Market size and forecast
4.4.6. Glycan Release Kits
18.104.22.168. Market size and forecast
22.214.171.124. Market size and forecast
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
126.96.36.199. Market size and forecast
188.8.131.52. Market size and forecast
184.108.40.206. Market size and forecast
220.127.116.11. Market size and forecast
CHAPTER 5 GLYCOMICS MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2.1. Market size and forecast
5.3. DRUG DISCOVERY & DEVELOPMENT
5.3.1. Market size and forecast
5.4.1. Market size and forecast
5.5.1. Market size and forecast
5.6.1. Market size and forecast
CHAPTER 6 GLYCOMICS MARKET, BY END USER
6.1.1. Market size and forecast
6.2. ACADEMIC RESEARCH INSTITUTES
6.2.1. Market size and forecast
6.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
6.3.1. Market size and forecast
6.4. CONTRACT RESEARCH ORGANIZATIONS
6.4.1. Market size and forecast
CHAPTER 7 GLYCOMICS MARKET, BY GEOGRAPHY
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
18.104.22.168. U.S. market size and forecast
22.214.171.124. Canada market size and forecast
126.96.36.199. Mexico market size and forecast
7.2.4. North America Glycomics Market by Product
7.2.5. North America Glycomics Market by Application
7.2.6. North America Glycomics Market by End User
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
188.8.131.52. Germany market size and forecast
184.108.40.206. France market size and forecast
220.127.116.11. UK market size and forecast
18.104.22.168. Spain market size and forecast
22.214.171.124. Rest of Europe market size and forecast
7.3.4. Europe Glycomics Market by Product
7.3.5. Europe Glycomics Market by Application
7.3.6. Europe Glycomics Market by End User
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
126.96.36.199. Japan market size and forecast
188.8.131.52. China market size and forecast
184.108.40.206. Australia market size and forecast
220.127.116.11. India market size and forecast
18.104.22.168. Rest of Asia-Pacific market size and forecast
7.4.4. Asia-Pacific Glycomics Market by Product
7.4.5. Asia-Pacific Glycomics Market by Application
7.4.6. Asia-Pacific Glycomics Market by End User
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
22.214.171.124. Brazil market size and forecast
126.96.36.199. Turkey market size and forecast
188.8.131.52. Saudi Arabia market size and forecast
184.108.40.206. South Africa market size and forecast
220.127.116.11. Rest of LAMEA market size and forecast
7.5.4. LAMEA Glycomics Market by Product
7.5.5. LAMEA Glycomics Market by Application
7.5.6. LAMEA Glycomics Market by End User
CHAPTER 8 COMPANY PROFILES
8.1. NEW ENGLAND BIOLABS
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. PROZYME, INC.
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. SHIMADZU CORPORATION
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. MERCK KGAA
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. TAKARA BIO INC.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. THERMO FISHER SCIENTIFIC
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. WATERS CORPORATION
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. AGILENT TECHNOLOGIES
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. BRUKER CORPORATION
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
7.10. Danaher Corporation
8.9.4. Operating business segments
8.9.5. Business performance
8.9.6. Key strategic moves and developments